Postdoctoral Fellow on development and implementation of novel electronic-structure methods and algorithms The Paul Scherrer Institute PSI is the largest research institute for natural and engineering sciences within Switzerland. We perform cutting-edge research in the fields of
General information Reference 2026-179 Information about Molecular Partners AG Founded in 2004 by a group of PhD students as a spin-off from the University of Zurich, Molecular Partners AG is a thriving and steadily growing clinical
ANYbotics is a fast-growing tech company dedicated to shaping the future of mobile robotics across multiple industries. Join our highly talented and motivated team of more than 200 people and work on cutting-edge robot technology. The
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
ANYbotics is a fast-growing tech company dedicated to shaping the future of mobile robotics across multiple industries. Join our highly talented and motivated team of more than 200 people and work on cutting-edge robot technology. The
Location: Geneva,Geneva,Switzerland Medicines for Malaria Venture (MMV) is the world’s leading product development partnership (PDP) dedicated to discovering, developing, and delivering affordable and effective antimalarial drugs. MMV collaborates with government agencies, private and public sector partners,
Principal Software Engineer – CoCounsel CoCounsel is our most advanced AI offering to date – combining generative and agentic AI capabilities to help legal professionals move beyond prompting and start delegating. As a Principal Software Engineer,
At ABB, we help industries run leaner and cleaner—and every person here makes that happen. You’ll be empowered to lead, supported to grow, and proud of the impact we create together. Join us and help run
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Microcaps is an ETH Zurich spin-off founded in March 2019. Our unique technology allows us to produce highly precise and innovative microcapsules that empower materials to unlock new capabilities; all tailored to various markets including cosmetics.
Minimum qualifications: Bachelors degree in Electrical Engineering, Computer Engineering, Computer Science, a related field, or equivalent practical experience. 10 years of experience with leading multiple design domains (Design For Test, Design Verification and Physical Design). 5
Huawei’s vision is to enrich lives through communication and intelligent innovation. As a global leader in information and communications technology (ICT), Huawei drives innovation in artificial intelligence, cloud computing, and smart device technologies. Through its Carrier,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Company Description At CERN, the European Organization for Nuclear Research, physicists and engineers are probing the fundamental structure of the universe. Using the worlds largest and most complex scientific instruments, they study the basic constituents of
Professor of Solid-State Materials The Department of Chemistry and Applied Biosciences (www.chab.ethz.ch) at ETH Zurich and the PSI Center for Neutron and Muon Sciences (CNM, www.psi.ch/en/cnm) at the Paul Scherrer Institute (PSI), Villigen (www.psi.ch) invite applications
Microcaps is an ETH Zurich spin-off founded in March 2019. Our unique technology allows us to produce highly precise and innovative microcapsules that empower materials to unlock new capabilities; all tailored to various markets from cosmetics
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,